You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

melphalan

Showing 1 - 25 of 444
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma, Newly Diagnosed Patients Trial in Torino (Melphalan, Lenalidomide, Prednisone)

Active, not recruiting
  • Multiple Myeloma
  • Newly Diagnosed Patients
  • Melphalan
  • +2 more
  • Torino, Italy
    Division of Hematology, AOU Città della Salute e della Scienza d
Mar 24, 2022

Multiple Myeloma Trial (Melphalan and Treosulfan, Melphalan)

Not yet recruiting
  • Multiple Myeloma
  • Melphalan and Treosulfan
  • Melphalan
  • (no location specified)
Dec 5, 2022

Leukemia, MDS Trial in Duarte (drug, procedure, radiation)

Active, not recruiting
  • Leukemia
  • Myelodysplastic Syndromes
  • fludarabine phosphate
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Feb 28, 2022

Multiple Myeloma Trial in Berne (Melphalan, Bendamustine)

Completed
  • Multiple Myeloma
  • Berne, Switzerland
    Department for Medical Oncology University Hospital/Inselspital
Jul 29, 2021

Leukemia Trial in Cleveland (Melphalan, Thiotepa, Fludarabine)

Recruiting
  • Leukemia
  • Melphalan
  • +3 more
  • Cleveland, Ohio
    University Hospitals Seidman Cancer Center, Case Comprehensive C
Jan 24, 2022

Hematopoietic Stem Cell Transplantation Trial in Cincinnati (Melphalan)

Completed
  • Hematopoietic Stem Cell Transplantation
  • Melphalan
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Aug 24, 2021

Multiple Myeloma, Amyloidosis Trial in New York (device, drug, procedure)

Active, not recruiting
  • Multiple Myeloma
  • Amyloidosis
  • Melphalan
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 21, 2022

Multiple Myeloma Trial in Torino (Cyclophosphamide, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Torino, Italy
    Division of Hematology, Molinette Hospital
Apr 6, 2022

Hematopoietic Stem Cell Transplantation Trial in Seoul (Melphalan)

Recruiting
  • Hematopoietic Stem Cell Transplantation
  • Melphalan
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Jun 23, 2021

Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell

Completed
  • Hematologic Malignancies
  • +7 more
  • Melphalan
  • San Francisco, California
    University of California, San Francisco
Sep 27, 2021

Retinoblastoma, Chemo Effect Trial in Guangzhou (Topotecan, Melphalan)

Recruiting
  • Retinoblastoma
  • Chemotherapy Effect
  • Guangzhou, Guangdong, China
    Sun Yat-sen University
Mar 12, 2021

Multiple Myeloma Trial in Atlanta, Chicago (procedure, drug, other)

Recruiting
  • Multiple Myeloma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +2 more
  • Atlanta, Georgia
  • +1 more
Feb 25, 2022

Hematologic Malignancies Trial in New York (Busulfan 3.2 mg/kg/day, Fludarabine, Melphalan)

Recruiting
  • Hematologic Malignancies
  • Busulfan 3.2 mg/kg/day
  • +5 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Mar 14, 2022

Adult Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult

Active, not recruiting
  • Adult Acute Lymphoblastic Leukemia in Remission
  • +6 more
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

Bilateral Retinoblastoma, Childhood Intraocular Retinoblastoma, Unilateral Retinoblastoma Trial (Biospecimen Collection,

Not yet recruiting
  • Bilateral Retinoblastoma
  • +2 more
  • Biospecimen Collection
  • +6 more
  • (no location specified)
Aug 17, 2022

Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Trial in Duarte (drug, other,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

Retinoblastoma Trial in Saint Louis (Melphalan)

Recruiting
  • Retinoblastoma
  • Melphalan
  • Saint Louis, Missouri
    Washington University School of Medicine (Saint Louis Children's
Feb 16, 2022

Sickle Cell Disease Trial in Hackensack (Alemtuzumab, Fludarabine, Melphalan)

Active, not recruiting
  • Sickle Cell Disease
  • Hackensack, New Jersey
    Hackensack University Medical Center
Feb 4, 2022

Plasma Cell Myeloma Trial in Seattle (biological, drug, procedure)

Recruiting
  • Plasma Cell Myeloma
  • Astatine At 211 Anti-CD38 Monoclonal Antibody OKT10-B10
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 27, 2022

Autologous Hematopoietic Stem Cell Transplant Recipient, Loss of Chromosome 17p, Plasma Cell Leukemia Trial in Duarte (drug,

Active, not recruiting
  • Autologous Hematopoietic Stem Cell Transplant Recipient
  • +4 more
  • Duarte, California
    City of Hope
Mar 17, 2022

Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma, Mixed Glioma Trial in Minneapolis, Portland (Carboplatin, Etoposide,

Completed
  • Anaplastic Oligoastrocytoma
  • +3 more
  • Minneapolis, Minnesota
  • +1 more
Mar 11, 2022

GVHD, Leukemia, Lymphoma Trial in Duarte (biological, drug, procedure, radiation, other)

Active, not recruiting
  • Graft Versus Host Disease
  • +2 more
  • rituximab
  • +8 more
  • Duarte, California
    City of Hope Medical Center
Mar 17, 2022

Plasma Cell Leukemia, Plasma Cell Myeloma Trial in Houston (procedure, biological, other, drug)

Active, not recruiting
  • Plasma Cell Leukemia
  • Plasma Cell Myeloma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 9, 2021

Multiple Myeloma Trial in Saint Petersburg (Melphalan, Nivolumab, Autologous Stem Cell Transplantation)

Recruiting
  • Multiple Myeloma
  • Melphalan
  • +2 more
  • Saint Petersburg, Russian Federation
    Boris V Afanasyev, MD, Prof.
Apr 4, 2022

Plasma Cell Leukemia, Plasmacytoma, Recurrent Plasma Cell Myeloma Trial in Houston (procedure, drug, other)

Active, not recruiting
  • Plasma Cell Leukemia
  • +3 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 22, 2022